Saku Biosciences
Biotechnology Research • • 1-10 Employees
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Founded | 2024 |
| Employees | 1-10 |
| Socials |
Key Contact at Saku Biosciences
Mark Van Zee
Co-founder and CEO
Saku Biosciences Email Formats
Saku Biosciences uses 3 email formats. The most common is {first initial} (e.g., j@sakubio.com), used 33.3% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@sakubio.com | 33.3% |
{first name} | john@sakubio.com | 33.3% |
{first name}.{last name} | john.doe@sakubio.com | 33.3% |
About Saku Biosciences
Saku Biosciences is an early stage life sciences company that aims to reduce the costs to make biotechnology products. We accomplish this by using directed cellular evolution using our groundbreaking PicoShell technology, a lab-on-a-particle technology that is the first high-throughput screening tool designed to increase yields. Saku Biosciences serves customers by offering contract services and cell/strain products that can can directly integrate into cell line developer and strain engineer workflows. By reducing the costs to make bioproducts, we will significantly broaden the impact of the biotechnology industry.
Saku Biosciences revenue & valuation
| Annual revenue | $427,775 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,400,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Saku Biosciences has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Saku Biosciences has never raised funding before.
Finland
Canada
Frequently asked questions
4.8
40,000 users
